Local recurrence following adjuvant chemotherapy without radiotherapy in completely resected stomach and gastroesophageal junction adenocarcinoma

Anticancer Research

Volumn 29, Issue 5, 2009, Pages 1853-1856

  Bar Sela, Gil ^a   Tsalic, Medy ^a   Steiner, Mariana ^b   Wollner, Mirjana ^a   Haim, Nissim ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b Lin Medical Center   (Israel)

Author keywords

Adjuvant chemotherapy; Local recurrence; Stomach carcinoma

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE;

ADJUVANT CHEMOTHERAPY; ANEMIA; ARTICLE; BLOOD TOXICITY; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS CARCINOMA; FEBRILE NEUTROPENIA; GASTRECTOMY; HUMAN; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; STOMACH NEOPLASMS;

EID: 67650074835     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Earle CC and Maroun JA: Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomized trials. Eur J Cancer 35: 1059-1064, 1999. (Pubitemid 29339187)
2. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H and Sasako M: Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Group trial. J Clin Oncol 22: 2069-2077, 2004. (Pubitemid 41095139)
3. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R and Torri V: Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerete). Ann Oncol 11: 837-843, 2000.
4. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM and Martenson JA: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730, 2001. (Pubitemid 34936653)
5. Valentini V and Cellini F: Radiotherapy in gastric cancer: a systematic review of literature and new perspectives. Expert Rev Anticancer Ther 7: 1379-1393, 2007. (Pubitemid 351826905)
6. Boige V, Pignon J, Saint-Aubert B, Lasser P, Conroy T, Bouche O, Segol P, Bedenne L, Rougier P, Ychou M. Final results of a randomized trial comparing preoperative 5-fluorouracil and cisplatin to surgery alone in adenocarcinoma of stomach and lower esophagus: FNLCC ACCORD07-FFCD 9703 trial. ASCO Annual Meeting, Abstract No. 4510, 2007.
7. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S and Chua YJ; MAGIC Trial Participants: Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355: 11-20, 2006.
8. Haim N, Tsalik M and Robinson E: Treatment of gastric adenocarcinoma with combination of etoposide, adriamycin and cisplatin (EAP): comparison between two schedules. Oncology 51: 102-107, 1994. (Pubitemid 24008650)
9. Preusser P, Wilke H, Achterrath W, Fink U, Lenaz L, Heinicke A, Meyer J, Meyer HJ and Buente H: Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7: 1310-1317, 1989. (Pubitemid 19220134)
10. Lodrick F and Siewert JR: Recent advances in multimodal treatment for gastric cancer: a review. Gastric Cancer 8: 78-85, 2005. (Pubitemid 40655516)
11. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A and Arai K; ACTS-GC Group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357: 1810-1820, 2007. (Pubitemid 350044801)
12. Gunderson LL and Sosin H: Adenocarcinoma of the stomach: areas of failure in a reoperation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8: 1-11, 1982.
13. Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F and Sullinger J: Patterns of failure following curative resection of gastric carcinoma. Int J Radiat Biol Phys 19: 1357-1362, 1990.
14. Coburn NG, Govindarajan A, Low CH, Guller U, Kiss A, Ringash J, Swallow CJ and Baxter NN: Stage-specific effect of adjuvant therapy following gastric cancer resection: a population-based analysis of 4,041 patients. Ann Surg Oncol 15: 2622-2623, 2008.
15. Kozak KR and Moody JS: The survival impact of the Intergroup 0116 trial on patients with gastric cancer. Int J Radiat Oncol Biol Phys 72: 517-521, 2008.